Global Bio-Layer Interferometry (BLI) Service Market Strategic Research Report

Scope of the Report

The global Bio-Layer Interferometry (BLI) Service market size is predicted to grow from US$ 345 million in 2025 to US$ 495 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

Bio-Layer Interferometry (BLI) Service measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.

The Bio - Layer Interferometry (BLI) service industry is experiencing rapid growth and presents several notable trends. Technologically, continuous innovation is a key trend. Manufacturers are dedicated to enhancing the sensitivity, throughput, and usability of BLI systems. For example, the next - generation BLI technology (NGB) has been introduced to meet the growing and diverse market demands. BLI is also being increasingly integrated with other technologies to provide more comprehensive and accurate analysis. The application scenarios of BLI are constantly expanding. It is not only widely used in the development of small - molecule drugs, antibody drugs, and protein drugs but also in emerging fields such as vaccine research and development, AAV, and LNP research. In addition, BLI is playing an important role in personalized medicine, enabling the analysis of specific patient responses at the molecular level. Moreover, with the continuous deepening of basic life science research and the development of biopharmaceuticals, as well as the increasing emphasis on biopharmaceuticals, the demand for BLI services in pharmaceutical research laboratories, contract research organizations (CROs), and biotechnology companies is surging.

This report presents a comprehensive overview of the global Bio-Layer Interferometry (BLI) Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• General Sensors
• Capture Sensors
• Antibody Sensors
• Others

Segment by Application

• Affinity and Kinetic Analysis
• Pharmaceutical Assay Development
• Protein Concentration Measurement
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Bio-Layer Interferometry (BLI) Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Affinity and Kinetic Analysis, Pharmaceutical Assay Development, Protein Concentration Measurement evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact